A new optical imaging system uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings are from a first pilot study of the new imaging system -- a noninvasive method of measuring blood flow dynamics in response to a single breath hold.